Montelukast, cysteinyl leukotriene receptor 1 antagonist, inhibits cardiac fibrosis by activating APJ

Montelukast, cysteinyl leukotriene receptor 1 (CysLT1R) antagonist, is used clinically for patients with asthma, chronic obstructive pulmonary diseases (COPD), and allergic rhinitis. It has been reported that CysLT1R antagonists could reduce the risks of cardiovascular diseases in animal studies. Ca...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pharmacology 2022-05, Vol.923, p.174892-174892, Article 174892
Hauptverfasser:	Wu, Yun, Cui, Chen, Bi, Fang-fang, Wu, Cheng-yu, Li, Jin-rui, Hou, Yu-meng, Jing, Ze-hong, Pan, Qing-ming, Cao, Miao, Lv, Li-fang, Li, Xue-lian, Shan, Hong-li, Zhai, Xin, Zhou, Yu-hong
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetates Animals APJ receptor Cardiac fibrosis CHO Cells Cricetinae Cricetulus Cyclopropanes Fibrosis Humans Mice Montelukast Quinolines Receptors, Leukotriene Sulfides Transforming Growth Factor beta
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!